Opening book details…
Can I read Proteases As Targets For Therapy (handbook Of Experimental Pharmacology) on EtoBox?
Proteases As Targets For Therapy (handbook Of Experimental Pharmacology) by S. Redshaw, N. A. Roberts, G. J. Thomas (auth.), Professor Klaus von der Helm Ph.D., M.D., Bruce D. Korant Ph.D., John C. Cheronis M.D., Ph.D. (eds.) is a nonfiction available to read on EtoBox.
What is Proteases As Targets For Therapy (handbook Of Experimental Pharmacology) about?
This volume is the first to combine latest information on viral, microbial and cellular proteolytic enzymes as potential targets for human therapeutics. Proteases control a large array of physiological reactions, and are involved in a variety of pathological processes for which effective medications are currently needed and/or being sought after. Although protease inhibitors have been investigated for many years, few have been employed therapeutically. Recent break- through by HIV protease inhibitors as therapeutic drugs has re-encouraged the search for inhibitors of other proteolytic enzymes. Klaus von der Helm, who described the first viral protease has brought leading experts together to discuss not only the success and problems of clinical use and continuing prospects, but to review further potential drug targets. This volume provides detailed information and evaluations of key viral, bacterial, fungal, and cellular proteases as potential future drug candidates.
Who reads Proteases As Targets For Therapy (handbook Of Experimental Pharmacology)?
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- S. Redshaw, N. A. Roberts, G. J. Thomas (auth.), Professor Klaus von der Helm Ph.D., M.D., Bruce D. Korant Ph.D., John C. Cheronis M.D., Ph.D. (eds.)
- Publisher
- Springer-Verlag Berlin Heidelberg
- Published
- 2000
- Language
- EN
- ISBN
- 9783642630231
- Category
- nonfiction
- Subjects
- Science, Chemistry, Medical
Other editions & translations
More by S. Redshaw, N. A. Roberts, G. J. Thomas (auth.), Professor Klaus von der Helm Ph.D., M.D., Bruce D. Korant Ph.D., John C. Cheronis M.D., Ph.D. (eds.)
Similar books
- Phosphodiesterases as Drug Targets (Handbook of Experimental Pharmacology, 204) — Christian Schudt, Armin Hatzelmann, Rolf Beume (auth.), Sharron H. Francis, Marco Conti, Miles D. Houslay (2011)
- Aspartic Acid Proteases as Therapeutic Targets: GHOSH:PROTEASES DRUG TARG — R. Mannhold, H. Kubinyi, G. Folkers (2010)
- Viral Proteases and Antiviral Protease Inhibitor Therapy : Proteases in Biology and Disease — Kuo-Chen Chou, Dong-Qing Wei, Qi-Shi Du (auth.), Uwe Lendeckel, Nigel M. Hooper (2009)
- Analgesia (Handbook of Experimental Pharmacology (177)) — Christoph Stein (2006)
- Acid Proteases: Structure, Function, And Biology (advances In Experimental Medicine And Biology) — Bent Foltmann, Vibeke Barkholt Pedersen (auth.), Jordan Tang (1977)
- Protein-Protein Interactions as New Drug Targets (Handbook of Experimental Pharmacology (186)) — K. L. Dodge-Kafka, A. Bauman, M. S. Kapiloff (auth.), Dr. Enno Klussmann, John Scott Ph.D. (2008)
